Pegaptanib

DRUG3 trials

Sponsors

Novartis Pharmaceuticals, Wake Forest University, Pfizer

Conditions

Age-related Macular DegenerationChoroidal NeovascularizationCystoid Macular EdemaMacular DegenerationNeovascular Macular DegenerationUveitis

Phase 3

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib

CompletedNCT00242580

Novartis PharmaceuticalsChoroidal Neovascularization, Macular Degeneration

Start: 2005-09-30Updated: 2016-03-31

Unknown Phase

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

CompletedNCT00790803

Wake Forest UniversityCystoid Macular Edema, Uveitis

Start: 2009-03-31End: 2012-03-31Updated: 2022-03-15

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

CompletedNCT01245387

PfizerAge-related Macular Degeneration, Macular Degeneration, Neovascular Macular Degeneration

Start: 2006-08-31End: 2009-12-31Updated: 2011-01-13